Lab Efficiency
Grupo Oncoclinicas reported a 65% boost in pathologist productivity after deploying Paige Prostate Detect.
Pharma ROI
Estimated savings of US $200k–500k per Phase II/III study via faster slide review & biomarker stratification.
Critical View
Published case studies remain sparse; revenue (~US $15m) implies <150 paid sites globally—well below the installed base of 1k scanners. Execution risk in scaling go-to-market is non-trivial.